4//SEC Filing
TRAVERSA SERGIO 4
Accession 0001213900-25-046085
CIK 0001553643other
Filed
May 19, 8:00 PM ET
Accepted
May 20, 6:01 PM ET
Size
8.7 KB
Accession
0001213900-25-046085
Insider Transaction Report
Form 4
TRAVERSA SERGIO
DirectorChief Executive Officer
Transactions
- Purchase
Common Stock
2025-05-20$0.56/sh+147,686$82,246→ 734,024 total - Purchase
Common Stock
2025-05-16$0.45/sh+172,314$77,472→ 556,338 total - Purchase
Common Stock
2025-05-19$0.50/sh+30,000$14,994→ 586,338 total
Footnotes (4)
- [F1]The number of securities reported represents an aggregate number of shares purchased in multiple open market transactions over a range of purchase prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares purchased by the Reporting Person at each separate price within the range.
- [F2]Purchase prices range from $0.4485 to $0.4564 per share, inclusive.
- [F3]Purchase prices range from $0.4998 to $0.50 per share, inclusive.
- [F4]Purchase prices range from $0.53 to $0.59 per share, inclusive.
Documents
Issuer
RELMADA THERAPEUTICS, INC.
CIK 0001553643
Entity typeother
Related Parties
1- filerCIK 0001565832
Filing Metadata
- Form type
- 4
- Filed
- May 19, 8:00 PM ET
- Accepted
- May 20, 6:01 PM ET
- Size
- 8.7 KB